INS and cystic fibrosis: Similarly, in a study of 20 pediatric and adult CF patients followed for 10.5 months after initiation of ETI, there was no change identified in insulin resistance or insulin secretion, as measured by the homeostasis model assessment (HOMA-IR) and c-peptide index, respectively [56].